First AD

Second AD

Current Barriers to uACR Testing

What are the current barriers to uACR testing?

How can these barriers to testing be addressed?

What are the guideline goals for reducing uACR? How much emphasis should be put on a multimodal approach to drive down uACR as much as possible?

How can increased awareness of CKD testing improve patient outcom

How can health care providers be engaged in promoting CKD testing?

Enhancing CKD Care in Type 2 Diabetes: Bridging Gaps in Diagnosis, Treatment, and Patient Outcomes

HCPLive® Peer Exchange panel discussions feature authoritative insights, opinions, and perspectives on important issues facing today's care professionals.

Peer Exchange

Barriers to urinary albumin-to-creatinine ratio (uACR) testing include limited awareness among healthcare providers, lack of standardized testing protocols, and insufficient patient education. Addressing these barriers requires enhancing provider education, implementing standardized testing guidelines, and increasing patient awareness. Guideline goals for reducing uACR emphasize a multimodal approach, integrating lifestyle changes, pharmacotherapy, and regular monitoring. Increased awareness of chronic kidney disease (CKD) testing can lead to earlier detection and improved patient outcomes. Engaging healthcare providers involves continuous education, integrating CKD testing into routine practice, and leveraging technology for better patient management.

Panelists discuss the current barriers to urine albumin-creatinine ratio (uACR) testing, strategies to address these barriers, the guideline goals for reducing uACR, and the importance of a multimodal approach, as well as how increased awareness of chronic kidney disease (CKD) testing can improve patient outcomes and engage health care providers in promoting testing.